gvhd

Showing 1 - 25 of 30

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

GVHD Trial (Grafalon, Thymoglobulin)

Not yet recruiting
  • GVHD
  • (no location specified)
Oct 9, 2023

GVHD, Acute Stem Cell Transplant Complications Trial in Chendu (Ruxolitinib)

Not yet recruiting
  • GVHD
  • Acute Stem Cell Transplant Complications
  • Chendu, Sichuan, China
    West China Hospital, Sichuan University
Oct 3, 2023

GVHD Trial in Shenzhen, Shanghai (PTCY)

Not yet recruiting
  • GVHD
  • Shenzhen, GaungDong, China
  • +1 more
Aug 17, 2023

GVHD, GVHD, Undefined Trial in United States (Photobiomodulation Therapy, Placebo sham device)

Recruiting
  • Graft-Versus-Host Disease
  • +2 more
  • Photobiomodulation Therapy
  • Placebo sham device
  • Bethesda, Maryland
  • +8 more
Jan 17, 2023

GVHD Trial in Germany, Spain, United States (Apraglutide)

Recruiting
  • GVHD
  • Stanford, California
  • +14 more
Nov 25, 2022

Autoimmune Diseases, Inflammatory Disease, Acquired Bone Marrow Aplasia Trial (Blood sample taken at a single time point)

Not yet recruiting
  • Autoimmune Diseases
  • +10 more
  • Blood sample taken at a single time point
  • (no location specified)
Sep 14, 2022

GVHD Trial in Hackensack (Telmisartan)

Active, not recruiting
  • GVHD
  • Hackensack, New Jersey
    Hackensack University Medical Center
Sep 2, 2022

Graft Vs Host Disease, GVHD Trial in Tampa, Minneapolis (Pacritinib, Sirolimus, Tacrolimus)

Active, not recruiting
  • Graft Vs Host Disease
  • GVHD
  • Tampa, Florida
  • +1 more
Jul 27, 2022

GVHD, GVHD, Acute-graft-versus-host Disease Trial in Canada, United States (Itolizumab, EQ001 Placebo)

Recruiting
  • Graft Versus Host Disease
  • +4 more
  • Itolizumab
  • EQ001 Placebo
  • Duarte, California
  • +5 more
Jul 5, 2022

GVHD Trial in New York (Bortezomib, Cyclophosphamide)

Active, not recruiting
  • GVHD
  • New York, New York
    New York University School of Medicine
Apr 15, 2022

Ocular Surface Disease in Chronic Graft-Versus-Host Disease

Recruiting
  • Dry Eye
  • GVHD
  • Cross-sectional study
  • Singapore, Singapore
    Cynthia Boo
Mar 22, 2022

GVHD, Hematologic Tumors Trial in La Jolla (Cyclophosphamide, abatacept, Methotrexate)

Recruiting
  • GVHD
  • Hematologic Neoplasms
  • La Jolla, California
    UC San Diego Moores Cancer Center
Mar 21, 2022

GVHD Trial (FMT)

Not yet recruiting
  • GVHD
  • FMT
  • (no location specified)
Oct 15, 2021

Acute-graft-versus-host Disease, aGVHD, GVHD Trial in United States (EQ001, EQ001 Placebo)

Recruiting
  • Acute-graft-versus-host Disease
  • +3 more
  • EQ001
  • EQ001 Placebo
  • Duarte, California
  • +18 more
Oct 1, 2021

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

GVHD, GVHD Trial in Tampa (Panobinostat, Sirolimus, Tacrolimus)

Completed
  • Graft Versus Host Disease
  • GVHD
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jul 19, 2021

Graft-versus-host-disease, GVHD Trial in United States (Alpha 1-Antitrypsin)

Completed
  • Graft-versus-host-disease
  • GVHD
  • Alpha 1-Antitrypsin
  • Duarte, California
  • +4 more
Jun 17, 2021

Engraft Failure, Relapse, GVHD Trial (decitabine, Acetylcysteine, Semustine)

Not yet recruiting
  • Engraft Failure
  • +2 more
  • (no location specified)
Jun 22, 2021

GVHD Trial in Minneapolis (CelluTome® Epidermal Harvesting System)

Withdrawn
  • GVHD
  • CelluTome® Epidermal Harvesting System
  • Minneapolis, Minnesota
    University of Minnesota
Apr 15, 2021

GVHD, Bone Marrow Transplant Failure, Alpha 1-Antitrypsin Trial in Israel

Active, not recruiting
  • GVHD
  • +2 more
    • Jerusalem, Center, Israel
    • +3 more
    Mar 9, 2021

    Leukemia, Lymphoma, MDS Trial in Moscow (CD45RA-depleted peripheral blood mononuclear cells)

    Unknown status
    • Leukemia
    • +5 more
    • CD45RA-depleted peripheral blood mononuclear cells
    • Moscow, Russian Federation
      Federal Research Center for pediatric hematology, oncology and i
    Feb 5, 2020

    After Allogeneic Hematopoietic Stem Cell Transplantation

    Completed
    • Allogeneic Stem Cell Transplantation
    • GVHD
      • Bologna, Italy
        Mario Arpinati
      Jan 17, 2019

      Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients

      Completed
      • Cytomegalovirus Infection
      • GVHD
        • Regensburg, Germany
          Universitätsklinikum Regensburg
        Aug 7, 2018

        Graft-vs-Host Disease, GVHD Trial in Boston (Brentuximab Vedotin)

        Terminated
        • Graft-vs-Host Disease
        • GVHD
        • Brentuximab Vedotin
        • Boston, Massachusetts
          Massachusetts General Hospital
        Jul 23, 2018